Projects per year
Abstract
Objectives: New Delhi metallo-β-lactamases (NDMs) are major contributors to the spread of carbapenem resistance globally. In Australia, NDMs were previously associated with international travel, but from 2019 we noted increasing incidence of NDM-positive clinical isolates. We investigated the clinical and genomic epidemiology of NDM carriage at a tertiary-care Australian hospital from 2016 to 2021. Methods: We identified 49 patients with 84 NDM-carrying isolates in an institutional database, and we collected clinical data from electronic medical record. Short- and long-read whole genome sequencing was performed on all isolates. Completed genome assemblies were used to assess the genetic setting of bla NDM genes and to compare NDM plasmids. Results: Of 49 patients, 38 (78%) were identified in 2019-2021 and only 11 (29%) of 38 reported prior travel, compared with 9 (82%) of 11 in 2016-2018 (P =.037). In patients with NDM infection, the crude 7-day mortality rate was 0% and the 30-day mortality rate was 14% (2 of 14 patients). NDMs were noted in 41 bacterial strains (ie, species and sequence type combinations). Across 13 plasmid groups, 4 NDM variants were detected: bla NDM-1, bla NDM-4, bla NDM-5, and bla NDM-7. We noted a change from a diverse NDM plasmid repertoire in 2016-2018 to the emergence of conserved bla NDM-1 IncN and bla NDM-7 IncX3 epidemic plasmids, with interstrain spread in 2019-2021. These plasmids were noted in 19 (50%) of 38 patients and 35 (51%) of 68 genomes in 2019-2021. Conclusions: Increased NDM case numbers were due to local circulation of 2 epidemic plasmids with extensive interstrain transfer. Our findings underscore the challenges of outbreak detection when horizontal transmission of plasmids is the primary mode of spread.
| Original language | English |
|---|---|
| Pages (from-to) | 709-716 |
| Number of pages | 8 |
| Journal | Infection Control & Hospital Epidemiology |
| Volume | 45 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - Jun 2024 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Projects
- 2 Finished
-
Integrating genomic and artificial intelligence approaches to combat antimicrobial resistance
Macesic, N. (Primary Chief Investigator (PCI))
NHMRC - National Health and Medical Research Council (Australia)
1/01/20 → 31/12/24
Project: Research
-
NOVEL SOLUTIONS FOR ANTIMICROBIAL RESISTANT PATHOGENS
Peleg, A. (Primary Chief Investigator (PCI))
1/01/17 → 31/12/21
Project: Research
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver